PTX 4.65% 4.1¢ prescient therapeutics limited

Ann: PTX-200 Phase 1B/2 Clinical Trial Update, page-8

  1. 1,735 Posts.
    lightbulb Created with Sketch. 619
    The result today was excellent.It will be interesting to see the market action over the next few weeks.,will the market wake up that the announcement that further undervalues the stock or will the market remain risk adverse and let it quietly go by, judging the announcement harshly in the current circumstances.

    On the other hand this announcement may attract interest from US investors bearing in mind that,it is cheap in US dollar terms, M&A activity is at record levels in the health care sector in the US, and it is basically a US company with directors having connections in the US and Paul Hooper in based in Los Angeles, but lets see what happens.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.1¢
Change
-0.002(4.65%)
Mkt cap ! $33.01M
Open High Low Value Volume
4.1¢ 4.2¢ 4.1¢ $1.449K 34.97K

Buyers (Bids)

No. Vol. Price($)
1 47170 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.2¢ 160224 1
View Market Depth
Last trade - 16.10pm 18/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.